Skip to content

Use of Ashwagandha Taila for Shiroabhyanga and Padabhyanga in Nidranash

Randomized Comparative Clinical Study to evaluate the efficacy of Shiroabhyanga and Padabhyanga with Ashwagandha Taila in the management of Nidranash with special reference to Primary Insomnia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/105050
Enrollment
68
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

None listed

Sponsors

Dr Kailas Atmaram Rathod
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 20 to 60 yr irrespective of gender, marital status, socioeconomic status. 2 Patient having sign and symptoms of Nidranash. 3 Patient willing to participate. 4 Patients with Controlled DM And HTN.

Exclusion criteria

Exclusion criteria: 1. Individuals below 20 years and above 60 years of age. 2. patient those are contraindicated for shiroabhyang and padaabhyang according to ayurved classics book 3. Patient with any dermatological manifestation effect. 4. lactating mother and pregnant women 5. patient with any other mental disorder on medication 6. patient who are suffering from other systematic diseases which interfere with our course of treatment.

Design outcomes

Primary

MeasureTime frame
Shiroabhyanga and Padabhyanga with Ashwagandha Taila is effective in the management of Nidranash with special reference to Primary Insomnia Timepoint: 1 to 7 Days follow up on 14th day

Secondary

MeasureTime frame
Improvement in Subjective and Objective Criteria Improvement in Quality of LifeTimepoint: 1 to 7 Days follow up on 14th day

Countries

India

Contacts

Public ContactDr Archana Suhas Wadkar

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Centre Ashta Sangli

archanaswadkar@gmail.com8888817891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026